WTR Healthcare Happenings
WTR Healthcare Happenings is a weekly conversation with healthcare executives, medical experts, and investors on recent clinical data or industry-driving events in healthcare.
WTR Healthcare Happenings
Latest Episodes
Cannara Biotech (LOVFF): Gaining Share in the Canadian Cannabis Market
In this episode, Cannara Biotech COO and Interim CFO Nick Sosiak joins WTR's Linda Bolton Weiser and Tim Gerdeman to discuss the company's expansion following the announcement of a long-term international supply agreement with Curaleaf carrying...
Oncolytics Biotech (ONCY): A Differentiated Approach to Treating Gastrointestinal Cancers
In this episode of WTR Healthcare Happenings, Oncolytics Biotech CEO Jared Kelly joins WTR's Tim Gerdeman and healthcare analyst Robert Sassoon to discuss the company's progress advancing pelareorep, its investigational oncolytic virus immunoth...
The Psychedelic Inflection Point: Big Pharma, FDA, and the Next Wave of Brain Medicines
In this episode of WTR Healthcare Happenings, Doug Drysdale, biopharma veteran and founder of Katagen, former CEO of Cybin (now Helus Pharma), joins WTR's Tim Gerdeman and analyst Robert Sassoon to explore whether psychedelic medicine has moved...
Pulsenmore (PLSM): Safe and Sound: Pulsenmore Brings Prenatal Ultrasound Home
Dr. Elazar Sonnenschein, Founder and CEO of Pulsenmore Ltd. (Nasdaq and Tel Aviv: PLSM), joins host Tim Gerdeman and WTR equity research analyst James Kisner on this episode of the WTR Healthcare Happenings Podcast. Pulsenmore has built the fir...
Biotech M&A Is Back: What's Driving the 2026 Deal Surge
In this episode of WTR Healthcare Happenings, host Tim Gerdeman is joined by healthcare equity research analyst Robert Sassoon to discuss the rebound in biotech and pharma M&A. Robert explains why 2026 is shaping up as the strongest M&A...